Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary New recruit expands senior team…
Retroviral vectors that are both non-replicating and non-integrating represent a novel and attractive tool that has potential advantages for gene…
Regulatory authorization will signal the first electronic technology to detect a disease CLEVELAND, May 20, 2025 /PRNewswire/ -- IdentifySensors Biologics,…
-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as…
-- First ever clinical data supporting safety and efficacy of Prime Editing in humans -- -- Initial data from first…
--Efficacy comparable to anti-IL4/IL13 antibody control --Achieved dose-dependent and durable target modulation in vivo without requiring degradation of STAT6 protein…
Presented new preclinical data in non-human primates (NHP) for alpha-1 antitrypsin deficiency (AATD) and phenylketonuria (PKU), where RNA Gene Writer…
Natural Nerve Pain Relief Guide by Jodi Knapp Offers Holistic, Non-Pharmaceutical Approach to Peripheral Neuropathy—Emphasizing Gut Health, Lifestyle Changes, and…
The new offering provides precise fetal risk assessment for up to 14 prevalent and actionable recessive and X-linked conditions, in…
First Quarter Revenues Grew 47% to $7.9 Million, Exceeding Management GuidanceRehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences…